Transcenta Holding Limited will convene its Annual General Meeting on 30 June 2026 at 10:00 a.m. (B6-501, 218 Xinghu Street, BioBay, Suzhou). Shareholders will vote on eight ordinary resolutions covering financial statements, board composition, auditor appointment and capital mandates.

Key agenda items:

1. FY 2025 Results • Adoption of the audited consolidated financial statements and the reports of directors and auditor for the year ended 31 December 2025.

2. Board Composition • Re-election of Executive Director Dr. Xueming Qian. • Re-election of Independent Non-executive Director (INED) Ms. Helen Wei Chen. • Authorisation for the board to set directors’ remuneration. • Appointment of Dr. Hansen Xu as Non-executive Director. • Appointment of Dr. Jun Bao as INED.

3. Auditor • Re-appointment of Ernst & Young as auditor with board-determined remuneration.

4. Capital Management • Share buy-back mandate: authorises the board to repurchase up to 10% of issued shares (excluding treasury shares) during the mandate period. • General issuance mandate: permits allotment or transfer of up to 20% of issued shares (excluding treasury shares). • Extension mandate: enlarges the issuance limit by the number of shares actually repurchased, capped at an additional 10% of issued share capital.

Administrative details:

• Record date for voting eligibility: 25 June 2026; share transfer registration closes from 25 June 2026 to 30 June 2026, both days inclusive. • Proxy forms must reach Tricor Investor Services or be submitted online by 10:00 a.m. on 28 June 2026. • All resolutions will be decided by poll, with results released via Hong Kong Exchanges and Clearing’s website and the company’s site.

The board currently comprises one Executive Director, one Non-executive Director and four INEDs. After the proposed appointments, the board size will increase to seven directors.